Buchumschlag

On the relative conservativeness of Bayesian logistic regression method in oncology dose‐finding studies

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Cheng‐Han Yang, Guanghui Cheng, Ruitao Lin
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Pharmaceutical Statistics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Drift Parameter Based Sample Size Determination in Multi‐Stage Bayesian Randomized Clinical Trials
von: Yueyang Han, et al.
Veröffentlicht: (2025)

Time‐to‐event estimands and loss to follow‐up in oncology in light of the estimands guidance
von: Jonathan M. Siegel, et al.
Veröffentlicht: (2024)

Shrinkage priors for isotonic probability vectors and binary data modeling, with applications to dose–response modeling
von: Philip S. Boonstra, et al.
Veröffentlicht: (2024)

Bayesian Hierarchical Models for Subgroup Analysis
von: Yun Wang, et al.
Veröffentlicht: (2024)

Bayesian Methods for Quality Tolerance Limit (QTL) Monitoring
von: J. C. Poythress, et al.
Veröffentlicht: (2024)

A Bayesian Hybrid Design With Borrowing From Historical Study
von: Zhaohua Lu, et al.
Veröffentlicht: (2024)

Prospectively Specified Adaptive Bayesian Borrowing: Considerations, Methodologies, and Implementations
von: Saurabh Mukhopadhyay, et al.
Veröffentlicht: (2025)

Bayesian Solutions for Assessing Differential Effects in Biomarker Positive and Negative Subgroups
von: Dan Jackson, et al.
Veröffentlicht: (2024)

Predictive Ppk calculations for biologics and vaccines using a Bayesian approach – a tutorial
von: Jos Weusten, et al.
Veröffentlicht: (2024)

Designing and Evaluating Bayesian Advanced Adaptive Randomised Clinical Trials: A Practical Guide
von: Anders Granholm, et al.
Veröffentlicht: (2025)

Comparing various Bayesian random‐effects models for pooling randomized controlled trials with rare events
von: Minghong Yao, et al.
Veröffentlicht: (2024)

Bayesian Response Adaptive Randomization for Randomized Clinical Trials With Continuous Outcomes: The Role of Covariate Adjustment
von: Vahan Aslanyan, et al.
Veröffentlicht: (2024)

Potential Bias Models With Bayesian Shrinkage Priors for Dynamic Borrowing of Multiple Historical Control Data
von: Tomohiro Ohigashi, et al.
Veröffentlicht: (2024)

Digital twins and Bayesian dynamic borrowing: Two recent approaches for incorporating historical control data
von: Carl‐Fredrik Burman, et al.
Veröffentlicht: (2024)

Bayesian Power‐Based Sample Size Determination for Single‐Arm Clinical Trials With Time‐to‐Event Endpoints
von: Go Horiguchi, et al.
Veröffentlicht: (2026)

Approximate Bayesian Analysis for Borrowing External Controls for Randomized Controlled Trials With Dynamic Borrowing and Covariate Balancing Adjustment
von: Jixian Wang, et al.
Veröffentlicht: (2025)

A Bayesian Dynamic Model‐Based Adaptive Design for Oncology Dose Optimization in Phase I/II Clinical Trials
von: Yingjie Qiu, et al.
Veröffentlicht: (2024)

Simulation‐Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case Studies
von: Chiara Micoli, et al.
Veröffentlicht: (2025)

A Dose‐Finding Design for Drug Combinations Using a Bayesian 4 Parameter Logistic Model With Penalised D‐Optimality
von: Maxine Ajimi, et al.
Veröffentlicht: (2026)

PKBOIN‐12: A Bayesian Optimal Interval Phase I/II Design Incorporating Pharmacokinetics Outcomes to Find the Optimal Biological Dose
von: Hao Sun, et al.
Veröffentlicht: (2024)

Balance diagnostics in propensity score analysis following multiple imputation: A new method
von: Sevinc Puren Yucel Karakaya, et al.
Veröffentlicht: (2024)

Experimental design considerations and statistical analyses in preclinical tumor growth inhibition studies
von: Vinicius Bonato, et al.
Veröffentlicht: (2024)

Penalized Variable Selection for Joint AFT Random‐Effect Model With Clustered Competing‐Risks Data
von: Lin Hao, et al.
Veröffentlicht: (2026)

A practical guide to the appropriate analysis of eGFR data over time: A simulation study
von: Todd DeVries, et al.
Veröffentlicht: (2024)

A Flexible Seamless Phase 2/3 Design With Biomarker‐Driven Subgroup Enrichment and Sample Size Re‐Estimation
von: Zizhong Tian, et al.
Veröffentlicht: (2025)

A case study: Assessing the efficacy of the revised dosage regimen via prediction model for recurrent event rate using biomarker data
von: Ahrim Youn, et al.
Veröffentlicht: (2024)

Predicting subgroup treatment effects for a new study: Motivations, results and learnings from running a data challenge in a pharmaceutical corporation
von: Björn Bornkamp, et al.
Veröffentlicht: (2024)

Great Wall: A Generalized Dose Optimization Design for Drug Combination Trials Maximizing Survival Benefit
von: Yan Han, et al.
Veröffentlicht: (2025)

Applying Bias Correction Methods to Build Hybrid Controls Using Real‐World Patients for a Phase IIb Randomized Controlled Trial of Baricitinib for Rheumatoid Arthritis
von: Heather J. Litman, et al.
Veröffentlicht: (2025)

Real Effect or Bias? Good Practices for Evaluating the Robustness of Evidence From Comparative Observational Studies Through Quantitative Sensitivity Analysis for Unmeasured Confounding
von: Douglas Faries, et al.
Veröffentlicht: (2024)

Frailty model with change points for survival analysis
von: Masahiro Kojima, et al.
Veröffentlicht: (2024)

Dynamic borrowing of historical controls adjusting for covariates in vaccine efficacy clinical trials
von: Andrea Callegaro, et al.
Veröffentlicht: (2024)

Simulation‐based sample size calculations of marginal proportional means models for recurrent events with competing risks
von: Julie Funch Furberg, et al.
Veröffentlicht: (2024)

Principles for Defining Estimands in Clinical Trials—A Proposal
von: Tobias Mütze, et al.
Veröffentlicht: (2024)

Quality by Design for Preclinical In Vitro Assay Development
von: Jonathan Jones, et al.
Veröffentlicht: (2024)

Applying the Estimand Framework to Non‐Inferiority Trials
von: Helle Lynggaard, et al.
Veröffentlicht: (2024)

Current developments of the estimand concept
von: Alexander Fierenz, et al.
Veröffentlicht: (2024)

Comparative Analyses of Bioequivalence Assessment Methods for In Vitro Permeation Test Data
von: Sami Leon, et al.
Veröffentlicht: (2024)

Futility Interim Analysis Based on Probability of Success Using a Surrogate Endpoint
von: Ronan Fougeray, et al.
Veröffentlicht: (2024)

Pre‐Posterior Distributions in Drug Development and Their Properties
von: Andrew P. Grieve
Veröffentlicht: (2024)